The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels.

Схожие документы

• Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.
  по: Burkhardt, K, et al.
  Опубликовано: (1989)
• Demonstration of two distinct forms of released low affinity-type rat IL-2 receptors.
  по: Herrmann, T, et al.
  Опубликовано: (1989)
• Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing IL-2 receptor positive tumours with high or low metastatic capacity.
  по: Schirrmacher, V., et al.
  Опубликовано: (1987)
• Studies on T lymphocyte activation. II. Monoclonal antibody inhibiting the capacity of rat T lymphoblasts to absorb and to respond to IL-2: an anti-IL-2 receptor antibody?
  по: Osawa, H, et al.
  Опубликовано: (1983)
• Cells reacting with the monoclonal anti-IL-2 receptor antibody AMT-13 in the regenerating thymus of irradiated mice.
  по: Takacs, L, et al.
  Опубликовано: (1986)